Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report
Abstract Combined oral contraceptives and factor V Leiden mutation are multiplicative risk factors for venous thromboembolism. However, it remains unknown whether this multiplicative effect is reflected in thrombin generation assays. We report here the evolution of the thrombin generation profile wh...
Main Authors: | Maxime G. Zermatten, Debora Bertaggia Calderara, Alessandro Aliotta, Lorenzo Alberio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12318 |
Similar Items
-
Dabigatran etexilate: a direct thrombin inhibitor
by: M. Dugnani
Published: (2013-05-01) -
Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience
by: Yong-Su Jang, et al.
Published: (2021-07-01) -
A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk
by: Marina Vinciguerra, et al.
Published: (2023-03-01) -
Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system
by: Laure Morimont, et al.
Published: (2022-03-01) -
Obesity and contraceptive use: impact on cardiovascular risk
by: Giuseppe M.C. Rosano, et al.
Published: (2022-12-01)